Counterpoint Mutual Funds’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,765
Closed -$85K 454
2022
Q3
$85K Buy
+34,765
New +$116K 0.21% 231
2022
Q2
Sell
-2,888
Closed -$19K 341
2022
Q1
$19K Sell
2,888
-293
-9% -$2.5K 0.01% 219
2021
Q4
$29K Buy
+3,181
New +$29.6K 0.03% 26

Other funds holding DBD

Counterpoint Mutual Funds's DBD Position: Q4 2022 in Review

Counterpoint Mutual Funds sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 34,765 shares — an estimated $85K sold.

Counterpoint Mutual Funds first reported a position in DBD in Q4 2021 and held it in 3 quarters. The position peaked at $85K in Q3 2022. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Counterpoint Mutual Funds reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 34,765 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $85K.
  • Counterpoint Mutual Funds first reported a position in Diebold Nixdorf Incorporated in Q4 2021 and held it in 3 quarters.
  • Counterpoint Mutual Funds's Diebold Nixdorf Incorporated position peaked at $85K in Q3 2022.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2022, filed 19 Jan 2023.